Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.300
-0.150 (-10.34%)
At close: Nov 28, 2025, 4:00 PM EST
1.320
+0.020 (1.54%)
Pre-market: Dec 1, 2025, 5:50 AM EST
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $2.36 million as of December 1, 2025. Its market cap has decreased by -18.77% in one year.
Market Cap
2.36M
Enterprise Value
-570.52K
1-Year Change
-18.77%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.50M to $2.36M, a decrease of -96.51%. That is a compound annual growth rate of -56.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 2.36M | -12.35% |
| Dec 31, 2024 | 2.69M | 78.03% |
| Dec 29, 2023 | 1.51M | -80.26% |
| Dec 30, 2022 | 7.66M | -84.66% |
| Dec 31, 2021 | 49.91M | -26.06% |
| Nov 10, 2021 | 67.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 287.99B |
| Merck & Co. | 259.69B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 223.51B |